Advertisement
Singapore markets close in 4 hours 29 minutes

  • Straits Times Index

    3,309.65
    -3.83 (-0.12%)
     

  • Nikkei

    39,182.43
    +395.05 (+1.02%)
     

  • Hang Seng

    19,650.18
    +96.57 (+0.49%)
     

  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     

  • Bitcoin USD

    66,670.59
    -387.23 (-0.58%)
     

  • CMC Crypto 200

    1,361.44
    -12.40 (-0.90%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • Dow

    40,003.59
    +134.19 (+0.34%)
     

  • Nasdaq

    16,685.97
    -12.33 (-0.07%)
     

  • Gold

    2,442.50
    +25.10 (+1.04%)
     

  • Crude Oil

    80.08
    +0.02 (+0.02%)
     

  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     

  • FTSE Bursa Malaysia

    1,629.06
    +12.44 (+0.77%)
     

  • Jakarta Composite Index

    7,312.95
    -4.29 (-0.06%)
     

  • PSE Index

    6,683.80
    +65.11 (+0.98%)
     

Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson ...

GuruFocus Research
·1-min read

Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics Inc (NASDAQ:CGEM), sold 63,606 shares of the company on May 7, 2024. The transaction was filed on the same day with the SEC.

Cullinan Therapeutics Inc (NASDAQ:CGEM) focuses on developing a portfolio of oncology and immuno-oncology therapies. The company aims to address unmet medical needs in the treatment of cancer through innovative therapeutic products.

The shares were sold at a price of $28.25 each, resulting in a total transaction amount of approximately $1,796,845. This sale by the insider is part of a broader trend observed over the past year, where there have been 30 insider sells and no insider buys at Cullinan Therapeutics Inc (NASDAQ:CGEM).

ADVERTISEMENT

Over the past year, Jennifer Michaelson has sold a total of 78,903 shares of Cullinan Therapeutics Inc (NASDAQ:CGEM) and has not purchased any shares. This recent sale represents a significant portion of those transactions.

The stock currently holds a market cap of approximately $1.19 billion. Investors and analysts monitor insider transactions such as this to gain insights into the company's performance and insider perspectives on the stock's valuation.

For more detailed valuation metrics, such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, investors can visit the respective links.

Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson Sells Shares
Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson Sells Shares

This insider trend image provides a visual representation of the selling and buying activities of insiders at Cullinan Therapeutics Inc (NASDAQ:CGEM) over the past year.

The recent insider sale by Jennifer Michaelson continues the trend of insider sales at Cullinan Therapeutics Inc (NASDAQ:CGEM), which may be of interest to current and potential investors for their decision-making processes.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.